Searched for
GBR 500
Beaten Jannik Sinner extends lead on Carlos Alcaraz at top of ATP rankingsJannik Sinner remains world number one despite losing the French Open final to Carlos Alcaraz, who stays at number two. Novak Djokovic clim...- Novak Djokovic extends record stay as world number oneSecond-ranked Alcaraz will take over at the ATP summit if he wins the Indian Wells Masters -- Djokovic was forced to withdraw from the even...
- View: Busting myths behind opposition to Adani mineContrary to the claims that Carmichael mine is a ‘super/mega mine’, it constitutes merely 2.5% of the total world thermal coal traded in 20...
- Glenmark rises armed with research after five year hiatusIt may be too early to forecast how Glenmark’s drugs will fare, for the next few years, the generics business will continue to be key.
- Worst bleaching on record for Great Barrier Reef: ScientistsThe results are based on the aerial surveys of more than 500 coral reefs from Cairns in Australia to Papua New Guinea.
- Great Barrier Reef may be off danger listOne of the world's greatest natural wonders - The Great Barrier Reef, home to 2,500 individual reefs, 400 types of coral, 1,500 species of ...
- Glenmark bullish on drug discovery pipeline, eyes partnershipsPain, inflammation and oncology are the therapeutic areas currently the drug maker is working on, said Glenn Saldanha, Chairman & Managing ...
- Glenmark opens new manufacturing facility in SwitzerlandGlenmark Pharmaceuticals opened a new manufacturing facility in Switzerland for supply of clinical trial material.
- Glenmark Pharma aims at Rs 5,000 crore revenue during FY13, focus on USGlenmark Pharmaceuticals today said it is aiming for up to 30 per cent growth in revenues this fiscal to touch Rs 5,000 crore.
- Glenmark enters phase II clinical trial for new drug moleculeGlenmark Pharmaceuticals said it has entered the phase II clinical trials for its new drug molecule aimed at treating ulcerative colitis.
- Glenmark Q4 net up 33 per cent at Rs 150 croreGlenmark Pharmaceuticals today said its consolidated net profit rose by 32.54 per cent to Rs 150.35 crore for the fourth quarter ended Marc...
- We anticipate margins between 22% to 23% for the full year: Glenn Saldanha, Glenmark Ltd.Glenn Saldanha, Chairman and Managing Director, Glenmark Ltd., in an interview with ET Now, speaks about the company’s performance in the q...
- Glenmark gets $25 mn from Sanofi as final upfront paymentGlenmark Pharmaceuticals today said it has received Rs 110 crore from Sanofi, as second tranche of oulicensing fee for a deal with French d...
- Glenmark receives $25 mn from Sanofi as upfront paymentFollowing that clearance, the deal has now become effective and Glenmark has also received the first upfront payment of USD 25 million, it ...
- Failures and doubting investors have not dissuaded Glenmark Pharma's Glenn SaldanhaGlenmark has netted over $200 million in milestone and upfront payments while it has spent about $120-130 million on research.
- Glenmark Pharma in $613-million licensing deal with SanofiGlenmark Pharmaceuticals has licensed a new biotech drug to France's Sanofi which has the potential to generate revenues of $613 million or...
- Biotech drugs to replace chemical entities Lipitor & Plavix as market leadersThe global pecking order of blockbusters may soon be heading for a major upheaval with biotech drugs toppling the present market leaders.
- Glenmark takes 17% knock, biggest in 2 monthsGlenmark, one of the top 10 pharma companies in India by market capitalisation, witnessed a sharp fall of 17% in its intra-day stock price ...
- Glenmark to start phase I clinical trials of GBR 500 in USDrug firm Glenmark pharmaceuticals on Friday said it will file an application with American health regulator US Food and Drug Administrator...
- 7Seas acquire IP rights of German company7Seas Technologies, a gaming company has acquired German-based neodelight.com, gaming division of Neokolor GBR.
Load More
